ד"ר אביב מגר

Aviv Mager MD

Senior physician and Head , Lipid clinic

Department of Cardiology, Rabin Medical CentePetah Tikva Israel

Education

Academic and other positions

Senior lecturer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv

Membership in professional societies

1988    Israel Heart Society

1997    Israel Society of Aviation and Space Medicine

1999   European Society of Cardiology

2005  Israel Heart Society, working group on cardiovascular epidemiology, secretary  

Research areas

Genetic and acquired risk factors for coronary artery disease, with focus on Homocysteine,  MTHFR genotypes. Plasma lipids.

Complications and high risk subgroups in acute myocardial infarction

Pericardial disease

List of publications 2008-2012

     Porter A, Assali AR, Zahalka A, Iakobishvili Z, Brosh D, Lev EI, Mager A, Battler A, Kornowski R, Hasdai D.

     Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus.

     Am Heart J. 2008;155:284

    Iakobishvili Z, Eisen A, Porter A, Cohen N, Abramson E, Mager A, Shapira Y, Sagie A, Battler A, Hasdai D.

     Acute coronary syndromes in patients with prosthetic heart valves-a case-series.

     Acute Card Care 2008;10:148-151.

     Mager A, Koren-Morag N, Shohat M, Dadashev A, Kornowski R, Battler A, Hasdai D.  

     Impact of Ethnicity and MTHFR Genotype on Age at Onset of CAD in Women in Israel.  

      Isr Med Assoc J. 2008;10:516-9.

      Mager A, Kornowski R, Murninkas D, Vaknin-Assa H, Urkabi S, Brosh D,   

      Battler A, Assali, MD

      Outcome of Emergency Percutaneous Coronary Intervention for Acute

      ST-Elevation Myocardial Infarction Complicated by Cardiac Arrest   

      Coron Artery Dis  2008;19:615-8 

      Mager A, Orvin K, Koren-Morag N, Lev IE, Assali A, Kornowski R, Battler A, Shohat M, Hasdai D.

Impact of homocysteine-lowering therapy on long-term outcome in patients with coronary artery disease and different MTHFR genotypes

       Am J Cardiol 2009;104:745-749  [No=14, IF=3.603]

      Lev EI, Solodky A, Harel A, Mager A,  Brosh , Assali A, Roller  M, Battler A,

      Kleiman NS, Kornowski R.

       Treatment of Aspirin Resistant Patients with Omega-3 Fatty Acids vs. Aspirin  

       Dose Escalation

       J Am Coll Cardiol. 2010 12;55(2):114-21 [No=2, IF=11.054]

      Iakobishvili Z, Porter A, Battler A, Behar S, Roth A, Atar S, Boyko V,

      Mager A, Hasdai D.

      Effect of narcotic treatment on outcomes of acute coronary syndromes.

      Am J Cardiol. 2010 1;105(7):912-6.

      Messika AH, Kaluski DN, Lev E, Iakobishvili Z, Shohat M, Hasdai D,    

      Mager A.

      Nutrigenetic impact of daily folate intake on plasma homocysteine and    

      folate levels in patients with different methylenetetrahydrofolate reductase 

      genotypes.

      Eur J Cardiovasc Prev Rehabil. 2010;17(6):701-5.

      Lev EI, Leshem-Lev D, Mager A, Vaknin-Assa H, Harel N, Zimra Y,

      Bental T, Greenberg G, Dvir D, Solodky A, Assali A, Battler A, Kornowski   

      R.

      Circulating endothelial progenitor cell levels and function in patients who   

      experienced late coronary stent thrombosis.

      Eur Heart J. 2010;31(21):2625-32.

     Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.

     The ratio of contrast volume to glomerular filtration rate predicts outcomes     

     after percutaneous coronary intervention for ST-segment elevation acute  

     myocardial infarction.

     Catheter Cardiovasc Interv. 2011;78(2):198-201.

    Greenberg G, Cohen E, Garty M, Iakobishvili Z, Sandach A, Behar S,  

    Shotan A,  Gottlieb S, Mager A, Battler A, Hasdai D.

    Outcomes of acute heart failure associated with acute coronary syndrome    

    versus other causes.

    Acute Card Care. 2011;13(2):87-92.

    Iakobishvili Z, Cohen E, Garty M, Behar S, Shotan A, Sandach A, Gottlieb

    S, Mager A,   

    Battler A, Hasdai D; Heart Failure Survey in Isarel (HFSIS) Investigators.

    Use of intravenous morphine for acute decompensated heart failure in      

    patients with and  without acute coronary syndromes.

    Acute Card Care. 2011 Jun;13(2):76-80.

    Perl L, Netzer A, Rechavia E, Bental T, Assali A, Codner P, Mager A,     

    Battler A, Kornowski R, Lev EI.

    Long-term outcome of patients with     

    antiphospholipid  syndrome who undergo  percutaneous coronary  

    intervention.

    Cardiology. 2012;122(2):76-82.